May 28, 2015

The U.S. Food and Drug Administration approved two treatments for irritable bowel syndrome with diarrhea (IBS-D) on Wednesday. 

May 11, 2015

GlaxoSmithKline pledges $20 million toward creation of Qura Therapeutics, a joint venture with the University of North Carolina at Chapel Hill dedicated to finding a cure for HIV.

January 22, 2015

The global therapeutics market for Irritable Bowel Syndrome is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023, representing a high compound annual growth rate of almost 9.9%, according to a report published Thursday by research and consulting firm GlobalData.

January 13, 2015

Walgreens on Tuesday announced the launch of Well Beyond HIV, a national campaign highlighting people aging well beyond their HIV diagnosis.

November 3, 2014

Coenzyme Q10 — a compound commonly sold as a dietary supplement — provides health benefits to persons suffering from Gulf War illness symptoms.

September 4, 2014

Thermalon last week showcased its Thermalon Eye Compress at the annual National Association of Chain Drug Stores Total Store Expo.

July 11, 2014

Lake Consumer Products, a subsidiary of Wisconsin Pharmacal Co., on Thursday acquired the exclusive North American rights to an over-the-counter product that addresses many of the key symptoms associated with premenstrual syndrome.

July 2, 2014

Actavis on Wednesday announced that its subsidiary Forest Labs has successfully completed its acquisition of Furiex Pharmaceuticals in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug, following approval.

April 28, 2014

Forest Labs and Furiex Pharmaceuticals on Monday announced that Forest will acquire Furiex for $95 per share, or approximately $1.1 billion in cash.

January 15, 2014

Zafgen on Wednesday announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome, a severe form of genetic obesity.

December 4, 2013

Ellen Smith has Ehlers-Danlos Syndrome (EDS), a progressive degenerative connective tissue disorder characterized by joint hypermobility, skin extensibility and tissue fragility.

December 2, 2013

Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

November 26, 2013

Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

November 20, 2013

Trigg Laboratories, makers of Wet personal lubricants, will be supporting World AIDS Day on Dec. 1 through the donation of more than 5,000 safe-sex kits and samples to local clinics across nine cities to help raise awareness around HIV/AIDS, the company announced Tuesday.

August 23, 2013

HIV continues to disproportionately affect African-Americans and Hispanics, prompting a recent seminar in New York that included pop singer Alicia Keys, New York Democratic Rep. Charlie Rangel and others.

July 8, 2013

Reporting their results July 8 in Cancer Cell, researchers say their successful laboratory tests in human MDS cells and mouse models of MDS provide a molecular target for designing new drugs to battle a syndrome with few effective treatments.

June 5, 2013

The Illinois Lottery will use the net proceeds from a new game to promote HIV/AIDS education, prevention and support, the agency said Wednesday.

December 21, 2012

The Food and Drug Administration has approved a drug to treat a condition that affects people who have had their intestines partially or completely removed, the agency said Friday.

August 20, 2012

MISSISSAUGA, Ontario — Through the support of Rexall’s vendors and partners, Rexall’s annual vendor golf classic raised more than Canadian $250,000 for the Rexall Foundation earlier this month.

The Foundation for Prader-Willi Research received a C$10,000 donation at the Aug. 14 event.  The Foundation for Prader-Willi Research is an organization dedicated to eliminating the challenges of Prader-Willi Syndrome, a rare genetic disorder, through the advancement of research.

July 16, 2012

UCB has launched a new drug for treating Parkinson's disease and restless legs syndrome, the company said Monday.

June 21, 2012

The Food and Drug Administration has approved a new indication for a Pfizer drug.

April 4, 2012

The Food and Drug Administration has approved a patch for treating restless legs syndrome and Parkinson's disease.

December 16, 2011

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

September 23, 2011

The Food and Drug Administration has approved a treatment made by Alexion Pharmaceuticals for a rare blood disorder that affects children.